![Michael Mendelsohn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Mendelsohn
Director/Board Member at
FOGHORN THERAPEUTICS INC.
Net worth: - $ as of 2026-06-29
Profile
Dr. Michael E. Mendelsohn, MD, is an Independent Director at Cyclerion Therapeutics, Inc., an Independent Director at Foghorn Therapeutics, Inc., a Chairman at Cardurion Pharmaceuticals LLC, a Chief Medical & Scientific Officer at Takeda Pharmaceutical Co., Ltd. and a President at Mendelsohn Consulting Group LLC. He is on the Board of Directors at Cyclerion Therapeutics, Inc. and Foghorn Therapeutics, Inc. Dr. Mendelsohn was previously employed as a President & Chief Scientific Officer by Ironwood Pharmaceuticals, Inc., a Venture Partner by SV Life Sciences Managers LLP, an Independent Director by Regado Biosciences, Inc., a Senior VP & Global Head-Cardiovascular Research by Merck Research Laboratories Massachusetts LLC, an Executive Director-MCRI by Tufts Medical Center, Inc., and a Chief Scientific Officer by Tufts University School of Medicine. He received his undergraduate degree from Amherst College and a doctorate degree from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 0 ( -.--% ) | - $ | 2026-06-29 |
Michael Mendelsohn active positions
| Companies | Position | Start |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Director/Board Member | 2017-03-31 |
Cardurion Pharmaceuticals, Inc.
 Cardurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of heart failure and cardiovascular diseases | Founder | 2016-04-30 |
Mendelsohn Consulting Group LLC | Founder | 2013-08-31 |
Former positions of Michael Mendelsohn
| Companies | Position | End |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2018-11-30 |
SV Health Managers LLP
 SV Health Managers LLP Investment ManagersFinance SVHM is a hands-on manager which focuses investments in the human life sciences sector (biotechnology/biopharmaceuticals, medical devices, healthcare services and healthcare information technology). Their geographic focus is on North America and Western Europe, but they consider investment opportunities in other regions where there is a well-developed life sciences sector. SVHM's invests in companies with a very high quality management team and a business model that could provide a strong increase in value, often with a key technology protectable by law. They may occupy a strong, preferably proprietary position in a large or niche market or may have an early position in a fast growing market. | Corporate Officer/Principal | 2017-06-30 |
Regado Biosciences, Inc.
 Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Director/Board Member | 2015-04-30 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | 2013-10-31 |
Tufts Medical Center, Inc.
 Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Founder | 2010-04-30 |
Training of Michael Mendelsohn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Regado Biosciences, Inc.
Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts Medical Center, Inc.
Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Health Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
SV Health Managers LLP
SV Health Managers LLP Investment ManagersFinance SVHM is a hands-on manager which focuses investments in the human life sciences sector (biotechnology/biopharmaceuticals, medical devices, healthcare services and healthcare information technology). Their geographic focus is on North America and Western Europe, but they consider investment opportunities in other regions where there is a well-developed life sciences sector. SVHM's invests in companies with a very high quality management team and a business model that could provide a strong increase in value, often with a key technology protectable by law. They may occupy a strong, preferably proprietary position in a large or niche market or may have an early position in a fast growing market. | Finance |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Cardurion Pharmaceuticals, Inc.
Cardurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of heart failure and cardiovascular diseases | Health Technology |
Cyclerion Therapeutics, Inc.
 Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Mendelsohn Consulting Group LLC |
- Stock Market
- Insiders
- Michael Mendelsohn
